UBS Group

UBS Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

UBS Group’s Portfolio GRCL Stock Details GRCL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$1.26M	Buy
2023 Q3	$6.66K	Sell
2023 Q2	$10.4K	Buy
2023 Q1	$4.78K	Sell
2022 Q4	$8.27K	Sell
2022 Q3	$13K	Buy
2022 Q1	–	Sell
2021 Q4	$10K	Buy
2021 Q3	–	Sell
2021 Q2	$5K	Buy